Astrana Health, Inc.
DE ˙ DB ˙ US03763A2078
32,20 € ↑0,80 (2,55%)
2026-06-05
DEL PRIS
SecurityDE:3AM / Astrana Health, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,368,079 shares
Latest Disclosed Value $ 33,544,621
Dimensional Fund Advisors Lp reports 12.52% increase in ownership of 3AM / Astrana Health, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 1,368,079 shares of Astrana Health, Inc. (DE:3AM) valued at $28,456,043 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,215,812 shares of Astrana Health, Inc.. This represents a change in shares of 12.52% during the quarter. The current value of the position is $44,052,144 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ASTRANA HEALTH COM NEW 03763A207 1,368,079 152,267 12.52 33,545 11.21 0.0015
2026-02-12 2025-12-31 13F ASTRANA HEALTH COM NEW 03763A207 1,215,812 -18,909 -1.53 30,165 -13.83 0.0063
2025-11-12 2025-09-30 13F ASTRANA HEALTH COM NEW 03763A207 1,234,721 -27,432 -2.17 35,007 11.48 0.0075
2025-08-12 2025-06-30 13F ASTRANA HEALTH COM NEW 03763A207 1,262,153 144,386 12.92 31,402 -9.40 0.0073
2025-05-13 2025-03-31 13F ASTRANA HEALTH COM NEW 03763A207 1,117,767 72,227 6.91 34,660 5.14 0.0086
2025-02-13 2024-12-31 13F ASTRANA HEALTH COM NEW 03763A207 1,045,540 101,192 10.72 32,968 -39.74 0.0079
2024-11-07 2024-09-30 13F ASTRANA HEALTH COM NEW 03763A207 944,348 12,993 1.40 54,711 44.83 0.0133
2024-08-09 2024-06-30 13F ASTRANA HEALTH COM NEW 03763A207 931,355 103,608 12.52 37,776 8.69 0.0099
2024-05-10 2024-03-31 13F ASTRANA HEALTH COM NEW 03763A207 827,747 59,227 7.71 34,757 18.07 0.0094
2024-02-07 2023-12-31 13F APOLLO MED HLDGS COM NEW 03763A207 768,520 59,895 8.45 29,438 34.66 0.0086
2023-11-09 2023-09-30 13F APOLLO MED HLDGS COM NEW 03763A207 708,625 105,565 17.50 21,862 14.71 0.0072
2023-08-09 2023-06-30 13F APOLLO MED HLDGS COM NEW 03763A207 603,060 108,239 21.87 19,058 5.62 0.0061
2023-05-12 2023-03-31 13F APOLLO MED HLDGS COM NEW 03763A207 494,821 83,754 20.37 18,045 150,266.67 0.0061
2023-02-09 2022-12-31 13F APOLLO MED HLDGS COM NEW 03763A207 411,067 31,214 8.22 12 -99.92 0.0036
2022-11-10 2022-09-30 13F APOLLO MED HLDGS COM NEW 03763A207 379,853 -17,770 -4.47 14,815 -3.45 0.0057
2022-08-12 2022-06-30 13F APOLLO MED HLDGS COM NEW 03763A207 397,623 -3,617 -0.90 15,344 -21.11 0.0055
2022-05-13 2022-03-31 13F APOLLO MED HLDGS COM 03763A207 401,240 22,761 6.01 19,449 -30.06 0.0060
2022-02-09 2021-12-31 13F APOLLO MED HLDGS COM 03763A207 378,479 27,416 7.81 27,810 -13.01 0.0084
2021-11-12 2021-09-30 13F APOLLO MED HLDGS COM 03763A207 351,063 105,825 43.15 31,969 107.55 0.0103
2021-08-12 2021-06-30 13F APOLLO MED HLDGS COM 03763A207 245,238 132,285 117.12 15,403 403.37 0.0049
2021-05-14 2021-03-31 13F APOLLO MED HLDGS COM 03763A207 112,953 27,886 32.78 3,060 96.91 0.0010
2021-03-08 2020-12-31 13F/A-2 APOLLO MED HLDGS COM 03763A207 85,067 47,294 125.21 1,554 129.20 0.0006
2021-02-11 2020-12-31 13F APOLLO MED HLDGS COM 03763A207 85,067 47,294 1,554 561.2222
2020-11-12 2020-09-30 13F APOLLO MED HLDGS COM 03763A207 37,773 0 0.00 678 8.83 0.0003
2020-08-13 2020-06-30 13F APOLLO MED HLDGS COM 03763A207 37,773 1,664 4.61 623 33.40 0.0003
2020-05-14 2020-03-31 13F APOLLO MED HLDGS COM 03763A207 36,109 0 0.00 467 -29.77 0.0002
2020-02-14 2019-12-31 13F APOLLO MEDICAL HLDGS COM 03763A207 36,109 -1,641 -4.35 665 0.00 0.0002
2019-11-12 2019-09-30 13F APOLLO MEDICAL HLDGS COM 03763A207 37,750 0 0.00 665 5.39 0.0003
2019-08-13 2019-06-30 13F APOLLO MEDICAL HLDGS COM 03763A207 37,750 0 0.00 631 -8.82 0.0002
2019-08-12 2019-03-31 13F/A-2 APOLLO MEDICAL HLDGS COM 03763A207 37,750 5,508 17.08 692 8.13 0.0003
2019-05-10 2019-03-31 13F APOLLO MEDICAL HLDGS COM 03763A207 37,750 5,508 692
2019-02-26 2018-12-31 13F/A-1 APOLLO MEDICAL HLDGS COM 03763A207 32,242 19,561 154.25 640 128.57 0.0003
2019-02-13 2018-12-31 13F APOLLO MEDICAL HLDGS COM 03763A207 32,242 19,561 640
2018-11-13 2018-09-30 13F APOLLO MEDICAL HLDGS COM 03763A207 12,681 12,681 280 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.